Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0672-2013Class I

Bausch and Lomb 27G sterile cannula packed in the Bausch and Lomb Amvisc 1.2% Sodium Hyaluronate ( Model...

Bausch & Lomb Incorporated / initiated 2012-11-15 / Terminated / root cause: manufacturing process

Bausch and Lomb, Incorporated began a recall of Bausch and Lomb 27G sterile cannula packed in the Bausch and Lomb Amvisc 1.2% Sodium Hyaluronate ( Model 59051, 59081, 59051L, 59081L) and Amvisc Plus 1.6%... on . FDA classified it as Class I and gives the reason as "Some disposable cannulas (with 4-digit lot numbers) provided with the Amvisc or Amvisc Plus OVD are not properly engaging to the Luer-Lock on the Amvisc and Amvisc Plus sterile glass syringes. The cannulas may leak...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0672-2013
Classification
Class I
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Bausch & Lomb Incorporated
Product
Bausch and Lomb 27G sterile cannula packed in the Bausch and Lomb Amvisc 1.2% Sodium Hyaluronate ( Model 59051, 59081, 59051L, 59081L) and Amvisc Plus 1.6% Sodium Hyaluronate (Model 60081, 60051, 60051L, 60081L) ophthalmic viscosurgical device. The 27G disposable cannula is attached to the syringe standard luer fitting to deliver the Amvis or Amvis Plus during use as a surgical aid in opthalmic anterior or posterior segment procedures.
Product code
HMX Cannula, Ophthalmic
Reason for recall
Some disposable cannulas (with 4-digit lot numbers) provided with the Amvisc or Amvisc Plus OVD are not properly engaging to the Luer-Lock on the Amvisc and Amvisc Plus sterile glass syringes. The cannulas may leak viscoelastic material or detach from the syringe during injection. In rare incidents, detachment has resulted in serious patient injury.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
The firm, Bausch & Lomb, initially notified their customers via telephone November 14, 2012 and sent a follow-up letter entitled "URGENT VOLUNTARY PRODUCT RECALL AND FIELD CORRECTION" on November 15, 2012 to their customers. The letter described the product, problem and actions to be taken. The customers were instructed to quarantine the product; identify the affected cannulas; and complete and return the attached Recall and Field Correction Acknowledgment Form via Fax to (800) 822-8918 or email at: [email protected]. Note: Based on your form selections, replacement cannulas will either be expedited directly to your facility or your Bausch & Lomb Sales Representative will contact you shortly to furnish replacements and properly dispose of the cannulas with 4-digit lot numbers in your product inventory. Please feel free to contact Customer Service with any questions or concerns at (800) 338-2020 (option 2, followed again by Option 2).
Quantity in commerce
2,515,760
Distribution
Worldwide distribution: USA including DC and PR; and countries of: Canada and Mexico accounts not available at this time.
Product codes and lots
Lot Numbers: 23632, 23633, 23639, 23640, 23647, 23801, 23811, 23863, 23886, 23897, 23920, 23933, 23972, 24022, 24025, 24028, 24257, 24323, 24436, B100003C, B100003E, B100003G, B100015A, B100015D, B100023A, B100023B, B100023C, B100023D, B100023E, B100039C, B100039D, B100039F, B100046A, B100046B, B100046C, B100058A, B100069A, B100069E, B110027D, B110028C, B110048A, B110048D, B110056A, B120011D, B120016A, B120046C, C100039A, C100039B, C10003B, C100046A, C100046B, C100046C, D090095B, D090096A, D090096C, D090097C, D090097D, D090097E, D090097G, D090105B, D090105C, D090105D, D100007B, D100007C, D100008A, D100008B, D100009A, D100011A, D100011B, D100011C, D100016A, D100016B, D100016C, D100016D, D100022A, D100022B, D100022C, D100022D, D100026A, D100026B, D100026C, D100026D, D100026E, D100030A, D100030B, D100030C, D100035A, D100035B, D100035C, D100035D, D100043A, D100043B, D100043C, D100044A, D100044B, D100044C, D100044D, D100044E, D100045A, D100045B, D100045C, D100045D, D100059A, D100059B, D100059C, D100060A, D100060B, D100061A, D100061B, D100080A, D100081A, D100081AR, D100081AS, D110015A, D110015B, D110016A, D110045A, D110046A, D110047A, D110070A, D110071A, D110072A, D110090A, D110090B, D110091A, D110092A, D110108A, D110108B, D110108BR, D120015A, D120015B, D120027A, D120028A, D120029A, D120029B, D120038B, D120039A, D120056B, D120068A, D120068B, E090105A, E100016A, E100016B, E100035A, E100035B, E100035C, E100045A, E100045B, E100059A, E100059B, E100060A, E100060B, E100060C, E100061A,   Amvisc 1.2% Sodium Hyaluronate ( Model 59051, 59081, 59051L, 59081L)  Amvisc Plus 1.6% Sodium Hyaluronate (Model 60081, 60051, 60051L, 60081L)

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0672-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0672-2013Class ITerminatedVoluntary: Firm initiated